Latest from NELLPC

Friday Letter 18/10/2019

Friday 18th October 2019

NEL LPC Office- Ongoing phone issues

Please be aware that our phone lines are still down, we may be able to take your call for a few moments, but the line is very unreliable due to ongoing technical issues and will cut out.

Further investigation and repairs are scheduled for next week, we hope to have the phones working again soon.

If you have an urgent query, please send us an email and we will endeavor to get back to you as soon as possible.

Thank you for your patience, we will inform you when our lines are working again.

RPS supporting pharmacists

The RPS has started a campaign to support pharmacists experiencing work stress.

“Yesterday we started our workforce well-being campaign. Have you or are you stressed at work? Is your workload unbearable? Please take a moment to fill out our survey to take the evidence to government to help bring change.  See more info here:

https://www.rpharms.com/recognition/all-our-campaigns/workforce-wellbeing

Hemant Patel said, “You have a chance to make the pharmacy world a better place. Please spend a few minutes to help the profession help pharmacists to manage better stress and mental health conditions”.

Reminder: Two weeks to claim your Aspiration Payment

Pharmacies only have two weeks left to claim their Aspiration Payment (part of the PQS scheme), the deadline is Friday 1st November at 11:59pm.

Contractors can only claim Aspiration Payments if they made a claim for at least one of the Quality Payment Schemes in 2018/19 (June 2018 and/or February 2019). The pharmacy must be claiming under the same ODS code as used in these claims.

Those wishing to claim this payment must do so via the Manage Your Service (MYS) application.

For more information, please see the PSNC guidance for this.

The Aspiration Payment claim is optional and will not affect your ability to claim for the PQS scheme, February 2020.

Reminder: CVD Update evening

NEL LPC Cardiovascular update

  • Coronary heart disease affects 1 in 4 men and 1 in 6 women; it is the single biggest killer in the UK.
  • We know that Inequalities in heart attack care ‘costing women’s lives’
  • Let’s help the heart of our communities in NE London.

NEL LPC are pleased to invite you to a CVD update that will be presented by Paul Wright.

Paul is the lead Cardiac Pharmacist at Barts Health NHS Trust He is currently co-chair of the UKCPA Cardiac Committee and Program Guardian for several cardiac topics for CPPE. He has a specialist interest in Heart Failure.

When: Thursday 7th November

Where: Epping Forest Best Western, 30 Oak Hill, Woodford Green, London IG8 9NY

Registration and refreshments at 7pm for a 7:40 pm start and finish by 9:30pm

Agenda

  • Introduction and overview of Heart Failure and the impact on NE London
  • The 10 year plan – focus on cardiovascular disease and opportunities for primary care
  • Brief update on AF
  • Hypertension update
  • Cardiovascular risk calculations (QRISK)
  • Lipid management
  • Supporting adherence and compliance with existing medicinal therapies
  • Summary, questions and next steps

Please click on this link to register: https://www.nellpc.org.uk/?p=31897

Take Action for the Future of Your Pharmacy

Those who are interested in planning ahead need to be informed about the key changes taking place and develop an action plan for new ways of working, that includes how new models of care will affect your staff, your digital and IT systems, how your premises are laid out and how the work around that is organised.

Your LPC is looking at each of the above and finding ways to help you take charge and your staff and customers to benefit.

Please complete the survey below, so that we can customise as much of what we do as possible to help you manage the fast-paced change and very different organisation within the Primary Care Networks

Recent Medicine Alerts

Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg, Ranitidine Effervescent Tablets 300mg

Recall of all unexpired stock of Ranitidine Effervescent Tablets from pharmacies by Teva UK.

Full Information on GOV.UK :Class 2 Medicines recall: Ranitidine Effervescent Tablets 150mg, Ranitidine Effervescent Tablets 300mg (EL (19)A/27)

Class 4 Medicines Defect Information: Rifadin (rifampicin) 150mg Capsules

Change to the Patient Information Leaflet concerning possible side effects for Rifadin (rifampicin) 150mg Capsules has not been implemented by the required timeline- Aventis Pharma Ltd t/a Sanofi

Full Information on GOV.UK : Class 4 Medicines Defect Information: Rifadin (rifampicin) 150mg Capsules (MDR 127-09/19)

Class 4 Medicines Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets

Potential side effects that are not mentioned on the Patient Information Leaflet for Xoneva 10mg/10mg gastro resistant tablets- Alliance Pharmaceuticals Ltd

Full Information on GOV.UK :
Class 4 Medicines Defect Information: Xonvea 10 mg/10 mg gastro-resistant tablets (MDR 025-10/19)

Please read through the above and take the appropriate action in your pharmacy, if you have not already done so. Please direct any queries or concerns relating to the above information to MHRA at info@mhra.gov.uk.

Update for LPCs on NPA activity, Sept 2019

NHSBSA starts publishing weekly gateway reports | Pharmacy Business

NHSBSA are publishing weekly reports so pharmacies can check whether they meet the gateway criteria for PQS.

Click here for the full article from Pharmacy Business

Record numbers of people in England will be offered a flu vaccine this winter

The following press release from GOV.UK estimates that flu vaccinations will reach record numbers this year in England, claiming 25 million people are to be offered free NHS flu jab this winter

Click here for the full report on the GOV.UK website

PCSE Pharmacy Bulletin for October 2019

RPS Annual Conference 2019: Medicines Safety

For all RPS members, please be reminded of their upcoming conference on Sunday 17 November 2019.

The conference includes a full agenda with various speakers, please be aware of the following highlights and visit the RPS website to find out more and book your place.

  • Putting Your Safety at the Forefront: Chaired by Danielle Hunt, Chief Executive, Pharmacist Support,
  • Global Patient Safety Challenge: Chaired by Alpana Mair, Head of Effective Prescribing and Therapeutics, Scottish Government and Polypharmacy Lead, World Health Organisation (WHO)
  • Shared Decision Making: Hosted in collaboration with the Royal College of General Practitioners

There is also be onsite professional childcare for all attendees. This MUST be booked in advance, and is also limited.

Please see the RPS webpage for more information and to register.

NHS Counter Fraud Authority Information

Please be aware of the following update from the NHS Counter Fraud Authority

The NHS Counter Fraud Authority (NHSCFA) is the organisation leading the fight against fraud, bribery and corruption affecting the NHS. An estimated £1.27 billion is lost to fraud and other economic crimes in the NHS every year. That is enough money to pay for over 40,000 community nurses or 408,000 hospital beds. It is taxpayers’ money that is taken away from patient care. The NHSCFA looks into all areas of NHS spend in order to evaluate the risk and error threat that could be posed.

Community pharmaceutical fraud is one of the NHSCFA’s priority action areas for 2019-2020 as outlined in the business plan (https://cfa.nhs.uk/resources/downloads/documents/corporate-publications/NHSCFA_business_plan_2019-20_v1.0.pdf).

The NHSCFA will work with NHS Business Services Authority (NHSBSA) to identify key areas of loss to fraud and identify potential fraud by contractors providing community pharmacy services.

The NHSCFA attended The Pharmacy Show 2019 on 6-7 October 2019 to engage with pharmaceutical professionals, raise awareness of NHS fraud and how we can work together to prevent and detect it. The majority of pharmacists are honest and hard-working, and we seek their support in rooting out the minority who let down their colleagues.

If you anyone suspects fraud is being committed against the NHS, you can report it to your Local Counter Fraud Specialist, or report it to the NHSCFA by either using the online reporting tool at https://cfa.nhs.uk/reportfraud  or calling the fraud and corruption reporting line on 0800 028 4060.

If you would like to find out more about community pharmaceutical fraud and its risk area, please see the link below to our Strategic Intelligence Assessment (SIA). Page 11 touches on the relevant area.

https://cfa.nhs.uk/resources/downloads/documents/corporate-publications/NHSCFA_Strategic_Intelligence_Assessment_2017_18_v1.0.pdf

Asthma training event 23/11/2019

Please see the flyer below for the upcoming Asthma London event on Saturday 23rd November.

Leave a Reply

Scroll To Top

This website uses cookies to give you the best experience. Please click the 'Accept' button to agree to the use of these cookies in accordance with our Cookie Policy and to close this bar.

For more information on the cookies we use, please see our Cookie Policy.

You can revoke your consent and edit your preferences at any time using the links in the website footer.
Cookie Policy